Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals

Zheng Dong Liang, Yan Long, Helen H.W Chen, Niramol Savaraj, Macus Tien Kuo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Platinum-based antitumor agents have been the mainstay in cancer chemotherapy for many human malignancies. Drug resistance is an important obstacle to achieving the maximal therapeutic efficacy of these drugs. Understanding how platinum drugs enter cells is of great importance in improving therapeutic efficacy. It has been demonstrated that human high-affinity copper transporter 1 (hCtr1) is involved in transporting cisplatin into cells to elicit cytotoxic effects, although other mechanisms may exist. In this communication, we demonstrate that cisplatin transcriptionally induces the expression of hCtr1 in time- and concentration-dependent manners. Cisplatin functions as a competitor for hCtr1-mediated copper transport, resulting in reduced cellular copper levels and leading to upregulated expression of Sp1, which is a positive regulator for hCtr1 expression. Thus, regulation of hCtr1 expression by cisplatin is an integral part of the copper homeostasis regulation system. We also demonstrate that Ag(I) and Zn(II), which are known to suppress hCtr1-mediated copper transport, can also induce hCtr1/Sp1 expression. In contrast, Cd(II), another inhibitor of copper transport, downregulates hCtr1 expression by suppressing Sp1 expression. Collectively, our results demonstrate diverse mechanisms of regulating copper metabolism by these heavy metals.

Original languageEnglish
Pages (from-to)17-27
Number of pages11
JournalJournal of Biological Inorganic Chemistry
Volume19
Issue number1
DOIs
Publication statusPublished - 2014 Jan 14

Fingerprint

Heavy Metals
Cisplatin
Copper
Platinum
Pharmaceutical Preparations
Chemotherapy
copper transporter 1
Drug Resistance
Metabolism
Antineoplastic Agents
Neoplasms
Homeostasis
Down-Regulation
Drug Therapy
Communication
Therapeutics

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Inorganic Chemistry

Cite this

Liang, Zheng Dong ; Long, Yan ; Chen, Helen H.W ; Savaraj, Niramol ; Kuo, Macus Tien. / Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals. In: Journal of Biological Inorganic Chemistry. 2014 ; Vol. 19, No. 1. pp. 17-27.
@article{da8de42c28ef438aa3f8b2f9bada77a1,
title = "Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals",
abstract = "Platinum-based antitumor agents have been the mainstay in cancer chemotherapy for many human malignancies. Drug resistance is an important obstacle to achieving the maximal therapeutic efficacy of these drugs. Understanding how platinum drugs enter cells is of great importance in improving therapeutic efficacy. It has been demonstrated that human high-affinity copper transporter 1 (hCtr1) is involved in transporting cisplatin into cells to elicit cytotoxic effects, although other mechanisms may exist. In this communication, we demonstrate that cisplatin transcriptionally induces the expression of hCtr1 in time- and concentration-dependent manners. Cisplatin functions as a competitor for hCtr1-mediated copper transport, resulting in reduced cellular copper levels and leading to upregulated expression of Sp1, which is a positive regulator for hCtr1 expression. Thus, regulation of hCtr1 expression by cisplatin is an integral part of the copper homeostasis regulation system. We also demonstrate that Ag(I) and Zn(II), which are known to suppress hCtr1-mediated copper transport, can also induce hCtr1/Sp1 expression. In contrast, Cd(II), another inhibitor of copper transport, downregulates hCtr1 expression by suppressing Sp1 expression. Collectively, our results demonstrate diverse mechanisms of regulating copper metabolism by these heavy metals.",
author = "Liang, {Zheng Dong} and Yan Long and Chen, {Helen H.W} and Niramol Savaraj and Kuo, {Macus Tien}",
year = "2014",
month = "1",
day = "14",
doi = "10.1007/s00775-013-1051-z",
language = "English",
volume = "19",
pages = "17--27",
journal = "Journal of Biological Inorganic Chemistry",
issn = "0949-8257",
publisher = "Springer Verlag",
number = "1",

}

Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals. / Liang, Zheng Dong; Long, Yan; Chen, Helen H.W; Savaraj, Niramol; Kuo, Macus Tien.

In: Journal of Biological Inorganic Chemistry, Vol. 19, No. 1, 14.01.2014, p. 17-27.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals

AU - Liang, Zheng Dong

AU - Long, Yan

AU - Chen, Helen H.W

AU - Savaraj, Niramol

AU - Kuo, Macus Tien

PY - 2014/1/14

Y1 - 2014/1/14

N2 - Platinum-based antitumor agents have been the mainstay in cancer chemotherapy for many human malignancies. Drug resistance is an important obstacle to achieving the maximal therapeutic efficacy of these drugs. Understanding how platinum drugs enter cells is of great importance in improving therapeutic efficacy. It has been demonstrated that human high-affinity copper transporter 1 (hCtr1) is involved in transporting cisplatin into cells to elicit cytotoxic effects, although other mechanisms may exist. In this communication, we demonstrate that cisplatin transcriptionally induces the expression of hCtr1 in time- and concentration-dependent manners. Cisplatin functions as a competitor for hCtr1-mediated copper transport, resulting in reduced cellular copper levels and leading to upregulated expression of Sp1, which is a positive regulator for hCtr1 expression. Thus, regulation of hCtr1 expression by cisplatin is an integral part of the copper homeostasis regulation system. We also demonstrate that Ag(I) and Zn(II), which are known to suppress hCtr1-mediated copper transport, can also induce hCtr1/Sp1 expression. In contrast, Cd(II), another inhibitor of copper transport, downregulates hCtr1 expression by suppressing Sp1 expression. Collectively, our results demonstrate diverse mechanisms of regulating copper metabolism by these heavy metals.

AB - Platinum-based antitumor agents have been the mainstay in cancer chemotherapy for many human malignancies. Drug resistance is an important obstacle to achieving the maximal therapeutic efficacy of these drugs. Understanding how platinum drugs enter cells is of great importance in improving therapeutic efficacy. It has been demonstrated that human high-affinity copper transporter 1 (hCtr1) is involved in transporting cisplatin into cells to elicit cytotoxic effects, although other mechanisms may exist. In this communication, we demonstrate that cisplatin transcriptionally induces the expression of hCtr1 in time- and concentration-dependent manners. Cisplatin functions as a competitor for hCtr1-mediated copper transport, resulting in reduced cellular copper levels and leading to upregulated expression of Sp1, which is a positive regulator for hCtr1 expression. Thus, regulation of hCtr1 expression by cisplatin is an integral part of the copper homeostasis regulation system. We also demonstrate that Ag(I) and Zn(II), which are known to suppress hCtr1-mediated copper transport, can also induce hCtr1/Sp1 expression. In contrast, Cd(II), another inhibitor of copper transport, downregulates hCtr1 expression by suppressing Sp1 expression. Collectively, our results demonstrate diverse mechanisms of regulating copper metabolism by these heavy metals.

UR - http://www.scopus.com/inward/record.url?scp=84891870734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891870734&partnerID=8YFLogxK

U2 - 10.1007/s00775-013-1051-z

DO - 10.1007/s00775-013-1051-z

M3 - Article

C2 - 24132751

AN - SCOPUS:84891870734

VL - 19

SP - 17

EP - 27

JO - Journal of Biological Inorganic Chemistry

JF - Journal of Biological Inorganic Chemistry

SN - 0949-8257

IS - 1

ER -